Found 7 matching trials
DAOIB Combined With tDCS for Early-phase Dementia
PHASE2This is a 24-week randomized, double-blind, placebo-controlled trial. We wi...
Location
Kaohsiung Chang Gung Memorial Hospital
The Dose Finding Study of DAOIB Added to tDCS for AD
PHASE2This is a 26-week randomized, double-blind, placebo-controlled trial. We wi...
Location
Kaohsiung Chang Gung Memorial Hospital
DAOIB for the Treatment of Mild Cognitive Impairment
PHASE2NMDA neurotransmission plays an important role in learning and memory. NMDA...
Location
Chang Gung Memorial Hospital
NMDA-enhancing Agent for the Treatment of Mild Cognitive Impairment
PHASE2NMDA neurotransmission plays an important role in learning and memory. NMDA...
Location
Kaohsiung Chang Gung Memorial Hospital
DAOIB for the Treatment of Cognitive Function and Behavioral and Psychological Symptoms of Dementia
PHASE2The population of dementia is increasing rapidly. Cognitive impairment as w...
Location
Chang Gung Memorial Hospital
Novel Augmentation of DAOIB and Antioxidant for Early Dementia
PHASE2Previous studies found that some NMDA-enhancing agents were able to improve...
Location
Chang Gung Memorial Hospital
NMDA Enhancement Combined With Omega-3 for Early Dementia
PHASE2In this 4-year proposed project, we will enroll 140 patients with aMCI or m...
Location
Kaohsiung Chang Gung Memorial Hospital